Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/IIa Trial Evaluating Safety of LOAd703, an Armed Oncolytic Adenovirus for Pancreatic Cancer

NCT02705196 is registered in ClinicalTrials.gov with Lokon Pharma AB as lead sponsor.

NCT NCT02705196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02705196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/IIa Trial Evaluating Safety of LOAd703, an Armed Oncolytic Adenovirus for Pancreatic Cancer
Lead sponsor
Lokon Pharma AB
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 2016
Completion date
November 15, 2025
Enrollment
51 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer